253 related articles for article (PubMed ID: 21932384)
21. Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis.
Chang LY; Li Y; Kaplan DE
Sci Rep; 2016 Nov; 6():36862. PubMed ID: 27857173
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
24. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
[TBL] [Abstract][Full Text] [Related]
25. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
[TBL] [Abstract][Full Text] [Related]
26. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
28. CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection.
Cagigi A; Du L; Dang LV; Grutzmeier S; Atlas A; Chiodi F; Pan-Hammarström Q; Nilsson A
PLoS One; 2009; 4(5):e5427. PubMed ID: 19412542
[TBL] [Abstract][Full Text] [Related]
29. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
30. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
31. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
[No Abstract] [Full Text] [Related]
32. Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.
Alisi A; Arciello M; Petrini S; Conti B; Missale G; Balsano C
PLoS One; 2012; 7(8):e44147. PubMed ID: 22937161
[TBL] [Abstract][Full Text] [Related]
33. CD27 synergizes with CD40 to induce IgM, IgG, and IgA antibody responses of peripheral blood B cells in the presence of IL-2 and IL-10.
Hirano T; Yonekubo I; Shimo K; Mizuguchi J
Immunol Lett; 2003 Oct; 89(2-3):251-7. PubMed ID: 14556986
[TBL] [Abstract][Full Text] [Related]
34. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
[TBL] [Abstract][Full Text] [Related]
35. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.
Morimoto S; Kanno Y; Tanaka Y; Tokano Y; Hashimoto H; Jacquot S; Morimoto C; Schlossman SF; Yagita H; Okumura K; Kobata T
J Immunol; 2000 Apr; 164(8):4097-104. PubMed ID: 10754303
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
Khatun M; Ray RB
Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
[TBL] [Abstract][Full Text] [Related]
37. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
[TBL] [Abstract][Full Text] [Related]
38. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.
Beishuizen CR; Kragten NA; Boon L; Nolte MA; van Lier RA; van Gisbergen KP
J Immunol; 2009 Nov; 183(10):6442-51. PubMed ID: 19864607
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
